Health News Releases

  • Today August 27
July 12, 2021 09:45
New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from two final analyses from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-lab
July 09, 2021 10:20
Kyalio Launches Day-to-Day Endo-Laparoscopic VR Surgical Library, the First in Asia
On July 1st, 2021, Kyalio and the Endoscopic and Laparoscopic Surgeons of Asia (ELSA), a leading surgical association with over 2,600 members, jointly launched the Day-to-Day Endo-Laparoscopic Virtual
July 08, 2021 11:40
New Survey by Patient Safety Movement Foundation Reveals Only Forty-Five Percent of Patients Feel in Control of Their Health
The COVID-19 pandemic took the world by storm in 2020 and drew attention to healthcare performance, access and resource use. Unfortunately, it took the impact of something as monumental as a worldwide
July 07, 2021 14:00
Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)
Alvotech, the Iceland-based biosimilar company, today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvo
July 07, 2021 11:25
Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction
The EMPEROR-Preserved Phase III trial met its primary endpoint, establishing empagliflozin as the first and only therapy to significantly reduce the risk of the composite of cardiovascular death or ho
July 07, 2021 10:30
New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients
Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Critical Care in which Dr. Tae Youn Kim and colleagues at the Dongguk University College of Medicine and Yonse
July 06, 2021 20:00
Allurion Technologies Unveils Transformed Allurion™ Weight Loss Program and New Corporate Brand
Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program. Allurion began co
July 02, 2021 16:10
Sentrx™ Animal Care, Inc. Announces Manufacturing Facility Expansion to Accommodate Accelerated Growth
On May 20th, 2021 Sentrx Animal Care held a ribbon cutting ceremony to celebrate the completion and opening of its brand new 22,000 square foot manufacturing facility in Salt Lake City, Utah. The expa
July 02, 2021 11:50
LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients
LG Chem announced topline results for the phase 2 study evaluating the efficacy and safety profiles of LC350189, a novel non-purine xanthine oxidase inhibitor for the chronic management of hyperuricem
July 02, 2021 11:10
Ferring Pharmaceuticals Announces Changes to Board of Directors
Ferring Pharmaceuticals announced today that Frederik Paulsen is stepping down from his role as Chairman of the Board of Directors[*] and transitioning to the role of Honorary Chairman. Lars Rebien Sø
July 02, 2021 10:50
Convert Group Study: COVID-19 Drew More Than 2.7 Billion Visits to Global ePharmacies in 96 Countries in Q1'21
Consumers and patients globally have turned to digital platforms to purchase their prescription (Rx), non-prescription (OTC) medication and parapharmacy products with more than 2.7 billion online visi
July 01, 2021 15:50
SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The par
July 01, 2021 14:00
Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) today announced submission of a New Drug Application (NDA) for its new anti-cancer d
June 30, 2021 11:50
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the “Annual Report”) wit
June 30, 2021 11:30
Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle® (follitropin delta) for Individualized Fertility Treatment
New data, presented today at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), show a comparable ongoing pregnancy rate of 31.3% with the individualised dos
June 29, 2021 11:20
Covetrus Introduces New Roles and Leadership Within Its North America & Global Businesses
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced the appointments of Bekki Kidd and András Bolcskei to the roles of head of North America Operations & Glob
June 29, 2021 10:15
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology company, today announced they have signed two exclusive 5-yea
June 28, 2021 17:25
Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes
The first data from Europe, Israel and East Asia in the EMPRISE real-world evidence study have been presented, revealing a risk reduction in cardiovascular outcomes associated with empagliflozin compa
June 28, 2021 16:30
Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute
Waters Corporation (NYSE:WAT) today announced an expansion of its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and R
Fresenius Medical Care's Korea Training Center
June 28, 2021 11:55
Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, recently announced the grand opening of its first training center in Korea, to offer
June 28, 2021 11:40
Cambridge University Spin-out Lucida Medical Joins GE Healthcare Edison™ Accelerator Programme
Cambridge start-up Lucida Medical has today announced that it has joined the Edison Accelerator, a programme designed by GE Healthcare in partnership with innovation organisation Wayra UK, to support
June 25, 2021 15:40
Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System
Invivoscribe, a global leader in precision diagnostics, has announced the launch of an Immune Biomarker Discovery grant program, focused on supporting development, validation and deployment of novel a
June 25, 2021 13:40
Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
Regulatory News: Abbas Hussain (56, British citizen) has a successful and international career of more than 30 years as an executive in the healthcare sector. From 2008 to 2017, Abbas Hussain held
June 25, 2021 11:10
Vifor Pharma to revise DIAMOND study, readout expected in H2 2021
Regulatory News: Vifor Pharma Group today announced that the phase-IIIb DIAMOND study has been amended with new and clinically relevant endpoints, including a new primary endpoint of efficacy in po
June 24, 2021 16:10
Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per Month
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that its partn
25 per page50 per page75 per page100 per page